Growth in the historic period resulted from aging population, risen number of contact lens users, increased funding from public and private research organizations, increased healthcare expenditure, increase in allergy diseases (hay fever) and increase in number of treatment option. Factors that negatively affected growth in the historic period were the low healthcare access, lack of awareness and impact COVID-19.
Going forward, rise in laser surgeries, change in working lifestyle, increasing prevalence of eye-related disorders, increasing geriatric population, growing burden of the diabetes and other comorbidities, side effects of other medication and promising pipeline for dry eye disease will drive market growth. Factors that could hinder the growth of the ophthalmology drugs market in the future include long and costly drug approvals, inadequate insurance coverage and expiration of patents.
The ophthalmology drugs market is segmented by type into antiglaucoma drugs, dry eye medication and other ophthalmological drugs. The other ophthalmological drugs was the largest segment of the ophthalmology drugs market by type, accounting for $30,182.1 million or 59.7% of the total market in 2021. The dry eye medication market is expected to be the fastest-growing segment going forward at a CAGR of 10.9%.
The ophthalmology drugs market is also segmented by distribution channel into hospital pharmacies, retail pharmacies/ drug stores and other distribution channels. The retail pharmacies/ drug stores market was the largest segment of the ophthalmology drugs market by distribution channel, accounting for $22,582.6 million or 44.7% of the total market in 2021. The other distribution channels market is expected to be the fastest-growing segment going forward at a CAGR of 9.1%.
The ophthalmology drugs market is also segmented by mode of purchase into prescription-based drugs and over-the-counter drugs. The prescription-based drugs market was the largest segment of the ophthalmology drugs market by mode of purchase, accounting for $30,014.54 million or 59.4% of the total market in 2021. The over-the-counter drugs market is expected to be the fastest-growing segment going forward at a CAGR of 9.2%.
The ophthalmology drugs market is also segmented by route of administration into topical, oral and other route of administrations. The topical market was the largest segment of the ophthalmology drugs market by route of administration, accounting for $30,341.62 million or 60.0% of the total market in 2021. The topical market is expected to be the fastest-growing segment going forward at a CAGR of 9.1%.
The ophthalmology drugs market is also segmented by drug classification into branded drugs and generic drugs. The branded drugs market was the largest segment of the ophthalmology drugs market by drug classification, accounting for $30,107.82 million or 59.5% of the total market in 2021. The generic drugs market is expected to be the fastest-growing segment going forward at a CAGR of 11.5%.
North America was the largest region in the ophthalmology drugs market, accounting for 37.3% of the global market in 2021. It was followed by Asia Pacific, Western Europe and the other regions. Going forward, the fastest growing regions in the ophthalmology drugs market will be Middle East and the South America, where growth will be at CAGRs of 11.4% and 9.9% respectively from 2021-2026.
The ophthalmology drugs market is moderately concentrated, with a few large players. The top ten competitors in the market made up to 49.98% of the total market in 2021. The market is expected to be change in near future with the adoption of acquisition and merger strategies by the players to enter and expand into newer geographies. Regeneron Pharmaceuticals Inc was the largest competitor with 11.46% of the market, followed by F. Hoffmann-La Roche Ltd with 9.11%, Novartis AG with 8.56%, Bayer AG with 6.82%, AbbVie Inc. with 6.35%, Santen Pharmaceutical Co., Ltd. with 3.83%, Alcon with 1.91%, Bausch Health Companies Inc. with 1.02%, Pfizer Inc. with 0.57%, and Teva Pharmaceutical Industries Ltd. with 0.36%.
The top growth potential in the ophthalmology drugs market by type will arise in the other ophthalmological drugs market, which will gain $16,427.7 million of global annual sales by 2026. The top growth potential in the ophthalmology drugs market by distribution channel will arise in the retail pharmacies/ drug stores market, which will gain $12,002.1 million of global annual sales by 2026. The top growth potential in the ophthalmology drugs market by mode of purchase will arise in the prescription-based drugs market, which will gain $15,620.2 million of global annual sales by 2026. The top growth potential in the ophthalmology drugs market by route of administration will arise in the topical market, which will gain $16,639.5 million of global annual sales by 2026. The top growth potential in the ophthalmology drugs market by drug classification will arise in the generic drugs market, which will gain $14,873.5 million of global annual sales by 2026. The ophthalmology drugs market size will gain the most in the usa at $8,734.8 million.
Market-trend-based strategies for the ophthalmology drugs market include develop innovative drugs, develop drugs with rho-kinase inhibitors to make the glaucoma drugs more effective, develop preservative free eye drops for the treatment of dry-eye syndrome, develop new mode of delivery systems for the treatment of dry-eye syndrome, invest in research and development of new and advanced drugs, develop non-steroidal anti-inflammatory ophthalmic drugs, develop combination therapies and consider acquiring smaller companies to diversify their product portfolio.
Player-adopted strategies in the ophthalmology drugs industry includes strengthening business operations through securing regulatory approvals, advancing investigational front-of-eye therapies through strategic acquisitions, strengthening business operations through expanding its geographic presence and expanding portfolio of eye care treatments through new product launches.
To take advantage of the opportunities, the publisher recommends the companies in the ophthalmology drugs market to focus on new modes of delivery systems, focus on product innovation for dry eye treatment, focus on improvement of combination therapies, expand in emerging markets, focus on partnerships and collaborations, provide competitively priced offerings, participate in trade shows and events and target cataract patients.
This report describes and explains the ophthalmology drugs market and covers 2016 to 2021, termed the historic period, and 2021 to 2026 termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.
Table of Contents
1. Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction and Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Ophthalmology Drugs Market Definition and Segmentations
6.4. Market Segmentation By Type
6.4.1. Antiglaucoma Drugs
6.4.2. Dry Eye Medication
6.4.3. Other Ophthalmological Drugs
6.5. Market Segmentation By Distribution Channel
6.5.1. Hospital Pharmacies
6.5.2. Retail Pharmacies/ Drug Stores
6.5.3. Other Distribution Channels
6.6. Market Segmentation By Route Of Administration
6.6.1. Topical
6.6.2. Oral
6.6.3. Others Route Of Administrations
6.7. Market Segmentation By Drug Classification
6.7.1. Branded Drugs
6.7.2. Generic Drugs
6.8. Market Segmentation By Mode Of Purchase
6.8.1. Over-The-Counter Drugs
6.8.2. Prescription Drugs
7. Product/Service Analysis -Product/Service Examples
7.1. Leading Products
7.2. New Products Approved
8. Supply Chain Analysis
8.1. Suppliers
8.1.1. Raw Material Suppliers
8.1.2. Contract Research Organization (CRO)
8.1.3. Ophthalmology Drugs Manufacturer
8.1.4. Contract Manufacturing Organization (CMO)
8.2. Distribution
8.2.1. Wholesalers/Distributors
8.2.2. Retailers (Pharmacies) And Hospitals
8.2.3. Ophthalmologists And Optometrists
8.3. End-Users
9. Customer Information
9.1. Electronic Devices And Ocular Manifestations During COVID-19
9.2. Amblyopia Is The Major Visual Problem In The Pediatric Age Group
9.3. Efficacy Of Interventions For Amblyopia
9.4. Loss Of Vision Is The Major Concern For Glaucoma Patients
9.5. The Majority Of The Patients Do not Seek Preventive Eye Care
9.6. Impact Of Dry Eye Disease (DED) On Patients’ Quality Of Life
9.7. Two-thirds Of Americans Suffer From Eye Problems
9.8. Americans Taking More Prescription Drugs than Ever
9.9. Increasing Intake of Prescription Drugs
10. Major Market Trends
10.1. Global Expansion And Acquisitions
10.2. Single Dose Preservative Free Eye Drops
10.3. Rising Research And Collaborations
10.4. Development Of New Mode Of Delivery Systems
10.5. Product Innovation For Dry Eye Treatment
10.6. New Product Development
10.7. Development Of Combination Therapies
10.8. Product Innovation For Thyroid Eye Disease (TED)
10.9. Innovative Drug Formulations To Reduce Postoperative Inflammation And Pain
10.10. New Rho-kinase Inhibitors for Glaucoma
11. Global Ophthalmology Drugs Market Size And Growth
11.1. Market Size
11.2. Historic Market Growth, 2016 - 2021, Value ($ Million)
11.2.1. Market Drivers 2016 - 2021
11.2.2. Aging Population
11.2.3. Market Restraints 2016 - 2021
11.3. Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.3.1. Market Drivers 2021 - 2026
11.3.2. Market Restraints 2021 - 2026
12. Ophthalmology Drugs Market, Regional Analysis
12.1. Global Ophthalmology Drugs Market, By Region, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.2. Global Ophthalmology Drugs Market, 2016 - 2026, Historic And Forecast, By Region
12.3. Global Ophthalmology Drugs Market, 2021 - 2026, Growth And Market Share Comparison, By Region
13. Global Ophthalmology Drugs Market Segmentation
13.1. Global Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.2. Global Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.3. Global Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.4. Global Ophthalmology Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.5. Global Ophthalmology Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14. Market Comparison with Macro Economic Factors
14.1. Ophthalmology Drugs Market Size, Percentage Of GDP, Global
14.2. Per Capita Average Ophthalmology Drugs Market Expenditure, Global
14.3. Ophthalmology Drugs Per Capita Expenditure, 2021, Major Countries
15. Asia-Pacific Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory Bodies
15.2.7. Major Associations
15.2.8. Taxes levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. Asia-Pacific Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.4. Asia-Pacific Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.5. Asia-Pacific Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.6. Asia-Pacific Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.7. Asia-Pacific Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.8. Asia-Pacific Ophthalmology Drugs Market, 2021, By Country, Value ($ Million)
15.9. Asia-Pacific Ophthalmology Drugs Market, 2016 - 2026, Historic And Forecast, By Country
15.10. Asia-Pacific Ophthalmology Drugs Market, 2021 - 2026, Growth And Market Share Comparison, By Country
15.11. Asia-Pacific Ophthalmology Drugs Market Metrics
15.11.1. Per Capita Ophthalmology Drugs Expenditure, 2021, Asia-Pacific Major Countries
15.12. Asia-Pacific Ophthalmology Drugs Market: Country Analysis
15.13. Australia Market
15.14. Australia Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.15. Australia Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.16. Australia Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.17. Australia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.18. Australia Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.19. Bangladesh Market
15.20. Bangladesh Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.21. Bangladesh Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.22. China Market
15.23. Summary
15.24. Market Overview
15.24.1. Country Information
15.24.2. Market Information
15.24.3. Background Information
15.24.4. Government Initiatives
15.24.5. Regulations
15.24.6. Regulatory Bodies
15.24.7. Major Associations
15.24.8. Taxes Levied
15.24.9. Corporate Tax Structure
15.24.10. Investments
15.24.11. Major Companies
15.25. China Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.26. China Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.27. China Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.28. China Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.29. China Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.30. Hong Kong Market
15.31. Hong Kong Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.32. Hong Kong Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.33. India Market
15.34. India Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.35. India Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.36. India Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.37. India Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.38. India Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.39. Indonesia Market
15.40. Indonesia Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.41. Indonesia Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.42. Indonesia Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.43. Indonesia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.44. Indonesia Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.45. Japan Market
15.46. Japan Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.47. Japan Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.48. Japan Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.49. Japan Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.50. Japan Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.51. Malaysia Market
15.52. Malaysia Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.53. Malaysia Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.54. New Zealand Market
15.55. New Zealand Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.56. New Zealand Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.57. Philippines Market
15.58. Philippines Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.59. Philippines Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.60. Singapore Market
15.61. Singapore Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.62. Singapore Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.63. South Korea Market
15.64. South Korea Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.65. South Korea Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.66. South Korea Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.67. South Korea Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.68. South Korea Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.69. Thailand Market
15.70. Thailand Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.71. Thailand Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.72. Vietnam Market
15.73. Vietnam Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.74. Vietnam Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16. Western Europe Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Western Europe Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.4. Western Europe Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.5. Western Europe Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.6. Western Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.7. Western Europe Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.8. Western Europe Ophthalmology Drugs Market, 2021, By Country, Value ($ Million)
16.9. Western Europe Ophthalmology Drugs Market, 2016 - 2026, Historic And Forecast, By Country
16.10. Western Europe Ophthalmology Drugs Market, 2021 - 2026, Growth And Market Share Comparison, By Country
16.11. Western Europe Ophthalmology Drugs Market Metrics
16.11.1. Per Capita Ophthalmology DrugsExpenditure, 2021,Western EuropeMajor Countries
16.12. Western Europe Ophthalmology Drugs Market: Country Analysis
16.13. Austria Market
16.14. Austria Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.15. Austria Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.16. Belgium Market
16.17. Belgium Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.18. Belgium Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.19. Denmark Market
16.20. Denmark Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.21. Denmark Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.22. Finland Market
16.23. Finland Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.24. Finland Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.25. France Market
16.26. France Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.27. France Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.28. France Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.29. France Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.30. France Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.31. Germany Market
16.32. Germany Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.33. Germany Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.34. Germany Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.35. Germany Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.36. Germany Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.37. Ireland Market
16.38. Ireland Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.39. Ireland Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.40. Italy Market
16.41. Italy Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.42. Italy Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.43. Netherlands Market
16.44. Netherlands Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.45. Netherlands Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.46. Norway Market
16.47. Norway Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.48. Norway Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.49. Portugal Market
16.50. Portugal Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.51. Portugal Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.52. Spain Market
16.53. Spain Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.54. Spain Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.55. Sweden Market
16.56. Sweden Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.57. Sweden Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.58. Switzerland Market
16.59. Switzerland Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.60. Switzerland Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.61. UK Market
16.62. UK Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.63. UK Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.64. UK Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.65. UK Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.66. UK Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17. Eastern Europe Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Eastern Europe Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
17.4. Eastern Europe Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
17.5. Eastern Europe Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.6. Eastern Europe Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.7. Eastern Europe Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.8. Eastern Europe Ophthalmology Drugs Market, 2021, By Country, Value ($ Million)
17.9. Eastern Europe Ophthalmology Drugs Market, 2016 - 2026, Historic And Forecast, By Country
17.10. Eastern Europe Ophthalmology Drugs Market, 2021 - 2026, Growth And Market Share Comparison, By Country
17.11. Eastern Europe Ophthalmology Drugs Market Metrics
17.11.1. Per Capita Ophthalmology Drugs Expenditure, 2021, Eastern Europe Major Countries
17.12. Eastern Europe Ophthalmology Drugs Market: Country Analysis
17.13. Czech Republic Market
17.14. Czech Republic Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
17.15. Czech Republic Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
17.16. Poland Market
17.17. Poland Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
17.18. Poland Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
17.19. Romania Market
17.20. Romania Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
17.21. Romania Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
17.22. Russia Market
17.23. Russia Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
17.24. Russia Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
17.25. Russia Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.26. Russia Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.27. Russia Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.28. Ukraine Market
17.29. Ukraine Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
17.30. Ukraine Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
18. North America Market
18.1. Summary
18.2. Market Overview
18.2.1. Region Information
18.2.2. Market Information
18.2.3. Background Information
18.2.4. Government Initiatives
18.2.5. Regulations
18.2.6. Regulatory Bodies
18.2.7. Major Associations
18.2.8. Taxes Levied
18.2.9. Corporate tax structure
18.2.10. Investments
18.2.11. Major Companies
18.3. North America Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
18.4. North America Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
18.5. North America Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
18.6. North America Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
18.7. North America Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
18.8. North America Ophthalmology Drugs Market, 2021, By Country, Value ($ Million)
18.9. North America Ophthalmology Drugs Market, 2016 - 2026, Historic And Forecast, By Country
18.10. North America Ophthalmology Drugs Market, 2021 - 2026, Growth And Market Share Comparison, By Country
18.11. North America Ophthalmology Drugs Market Metrics
18.11.1. Per Capita Ophthalmology Drugs Expenditure, 2021, North America Major Countries
18.12. North America Ophthalmology Drugs Market: Country Analysis
18.13. Canada Market
18.14. Canada Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
18.15. Canada Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
18.16. Mexico Market
18.17. Mexico Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
18.18. Mexico Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
18.19. USA Market
18.20. Summary
18.21. Market Overview
18.21.1. Country Information
18.21.2. Market Information
18.21.3. Background Information
18.21.4. Government Initiatives
18.21.5. Regulations
18.21.6. Regulatory Bodies
18.21.7. Major Associations
18.21.8. Tax Levied
18.21.9. Corporate Tax Structure
18.21.10. Investments
18.21.11. Major Companies
18.22. USA Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
18.23. USA Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
18.24. USA Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
18.25. USA Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
19. South America Market
19.1. Summary
19.2. Market Overview
19.2.1. Region Information
19.2.2. Market Information
19.2.3. Background Information
19.2.4. Government Initiatives
19.2.5. Regulations
19.2.6. Regulatory Bodies
19.2.7. Major Associations
19.2.8. Taxes Levied
19.2.9. Corporate Tax Structure
19.2.10. Investments
19.2.11. Major Companies
19.3. South America Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
19.4. South America Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
19.5. South America Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
19.6. South America Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
19.7. South America Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
19.8. South America Ophthalmology Drugs Market, 2021, By Country, Value ($ Million)
19.9. South America Ophthalmology Drugs Market, 2016 - 2026, Historic And Forecast, By Country
19.10. South America Ophthalmology Drugs Market, 2021 - 2026, Growth And Market Share Comparison, By Country
19.11. South America Ophthalmology Drugs Market Metrics
19.11.1. Per Capita Ophthalmology Drugs Expenditure, 2021, South America Major Countries
19.12. South America Ophthalmology Drugs Market: Country Analysis
19.13. Argentina Market
19.14. Argentina Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
19.15. Argentina Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
19.16. Brazil Market
19.17. Brazil Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
19.18. Brazil Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
19.19. Brazil Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
19.20. Brazil Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
19.21. Brazil Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
19.22. Chile Market
19.23. Chile Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
19.24. Chile Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
19.25. Colombia Market
19.26. Colombia Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
19.27. Colombia Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
19.28. Peru Market
19.29. Peru Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
19.30. Peru Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
20. Middle East Market
20.1. Summary
20.2. Market Overview
20.2.1. Region Information
20.2.2. Market Information
20.2.3. Background Information
20.2.4. Government Initiatives
20.2.5. Regulations
20.2.6. Regulatory Bodies
20.2.7. Major Associations
20.2.8. Taxes Levied
20.2.9. Corporate Tax Structure
20.2.10. Investments
20.2.11. Major Companies
20.3. Middle East Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
20.4. Middle East Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
20.5. Middle East Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
20.6. Middle East Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
20.7. Middle East Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
20.8. Middle East Ophthalmology Drugs Market, 2021, By Country, Value ($ Million)
20.9. Middle East Ophthalmology Drugs Market, 2016 - 2026, Historic And Forecast, By Country
20.10. Middle East Ophthalmology Drugs Market, 2021 - 2026, Growth And Market Share Comparison, By Country
20.11. Middle East Ophthalmology Drugs Market Metrics
20.11.1. Per Capita Ophthalmology Drugs Expenditure, 2021, Middle East Major Countries
20.12. Middle East Ophthalmology Drugs Market: Country Analysis
20.13. Iran Market
20.14. Iran Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
20.15. Iran Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
20.16. Israel Market
20.17. Israel Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
20.18. Israel Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
20.19. Saudi Arabia Market
20.20. Saudi Arabia Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
20.21. Saudi Arabia Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
20.22. Turkey Market
20.23. Turkey Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
20.24. Turkey Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
20.25. UAE Market
20.26. UAE Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
20.27. UAE Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
21. Africa Market
21.1. Summary
21.2. Market Overview
21.2.1. Region Information
21.2.2. Market Information
21.2.3. Background Information
21.2.4. Government Initiatives
21.2.5. Regulations
21.2.6. Regulatory Bodies
21.2.7. Major Associations
21.2.8. Taxes levied
21.2.9. Corporate Tax Structure
21.2.10. Investments
21.2.11. Major Companies
21.3. Africa Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
21.4. Africa Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
21.5. Africa Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
21.6. Africa Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
21.7. Africa Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
21.8. Africa Ophthalmology Drugs Market, 2021, By Country, Value ($ Million)
21.9. Africa Ophthalmology Drugs Market, 2016 - 2026, Historic And Forecast, By Country
21.10. Africa Ophthalmology Drugs Market, 2021 - 2026, Growth And Market Share Comparison, By Country
21.11. Africa Ophthalmology Drugs Market Metrics
21.11.1. Per Capita Ophthalmology Drugs Expenditure, 2021, Africa Major Countries
21.12. Africa Ophthalmology Drugs Market: Country Analysis
21.13. Egypt Market
21.14. Egypt Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
21.15. Egypt Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
21.16. Nigeria Market
21.17. Nigeria Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
21.18. Nigeria Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
21.19. South Africa Market
21.20. South Africa Ophthalmology Drugs Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
21.21. South Africa Ophthalmology Drugs Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
22. Competitive Landscape And Company Profiles
22.1. Company Profiles
22.2. Regeneron Pharmaceuticals Inc
22.2.1. Company Overview
22.2.2. Products And Services
22.2.3. Business Strategy
22.2.4. Financial Overview
22.3. F. Hoffmann-La Roche Ltd
22.3.1. Company Overview
22.3.2. Products And Services
22.3.3. Business Strategy
22.3.4. Financial Overview
22.4. Novartis AG
22.4.1. Company Overview
22.4.2. Products And Services
22.4.3. Business Strategy
22.4.4. Financial Overview
22.5. Bayer AG
22.5.1. Company Overview
22.5.2. Products And Services
22.5.3. Business Strategy
22.5.4. Financial Overview
22.6. AbbVie Inc.
22.6.1. Company Overview
22.6.2. Products And Services
22.6.3. Business Strategy
22.6.4. Financial Overview
23. Key Mergers And Acquisitions
23.1. Alcon to Acquire Aerie Pharmaceuticals, Inc.,
23.2. Théa Pharma acquired Akorn Operating Company LLC
23.3. Dr. Reddy’s acquire Slayback’s eyedrop rights
23.4. Stada Arzneimittel AG Acquired Biopharma LLC
23.5. Fidia Farmaceutici S.P.A. Acquired Ophthalmic Products From Novartis Farma Spain
23.6. Novartis Acquired Ophthalmic Solution Xiidra From Takeda Pharmaceutical
23.7. Biogen Inc. Acquired Nightstar Therapeutics Limited
24. Market Background: Pharmaceutical Drugs Market Characteristics
24.1. Pharmaceutical Drugs Market Characteristics
24.1.1. Market Definition
24.1.2. Market Segmentation By Product Type
24.2. Global Pharmaceutical Market, Segmentation By Type, 2016 - 2026, Value ($ Billion)
24.3. Global Pharmaceutical Market, 2021, By Region, Value ($ Billion)
24.4. Global Pharmaceutical Market, 2016 - 2026, Historic And Forecast, By Region
25. Opportunities And Strategies
25.1. Global Ophthalmology Drugs Market In 2026 - Countries Offering Most New Opportunities
25.2. Global Ophthalmology Drugs Market In 2026 - Segments Offering Most New Opportunities
25.3. Global Ophthalmology Drugs Market In 2026 - Growth Strategies
25.3.1. Market Trend Based Strategies
25.3.2. Competitor Strategies
26. Ophthalmology Drugs Market, Conclusions And Recommendations
26.1. Conclusions
26.2. Recommendations
26.2.1. Product
26.2.2. Place
26.2.3. Price
26.2.4. Promotion
26.2.5. People
27. Appendix
27.1. Market Data Sources
27.2. Research Methodology
27.3. Currencies
27.4. About the Publisher
27.5. Copyright and Disclaimer
Executive Summary
Ophthalmology Drugs Global Market Opportunities And Strategies To 2031 provides the strategists; marketers and senior management with the critical information they need to assess the global ophthalmology drugs market as it emerges from the COVID-19 shut down.Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider ophthalmology drugs market; and compares it with other markets.
The report covers the following chapters:
Introduction and Market CharacteristicsBrief introduction to the segmentations covered in the market, definitions and explanations about ophthalmology drugs market.
- Product Analysis
- Supply Chain
- Customer Information
Key Trends
Highlights the major trends shaping the global ophthalmology drugs market. This section also highlights likely future developments in the market.
Global Market Size and Growth
Global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis
Market Segmentation
Contains the market values (2016-2031) and analysis for for segment by type, by distribution channel, by route of administration, by drug classification and by mode of purchase in the market.
Regional Market Size and Growth
Regional market size (2021), historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape
Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Key Mergers and Acquisitions
Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Market Opportunities And Strategies
Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations
This section Includes recommendations for ophthalmology drugs providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix
This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope
Markets Covered
1) By Type: Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/Drug Stores; Other Distribution Channels
3) By Route Of Administration: Topical; Oral; Other Route Of Administrations
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Over-The-Counter Drugs; Prescription-Based Drugs
Companies Mentioned: Regeneron Pharmaceuticals Inc.; F. Hoffmann-La Roche Ltd.; Novartis AG; Bayer AG; AbbVie Inc
Countries: Australia; China; Bangladesh; India; Indonesia; Japan; South Korea; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; ophthalmology drugs indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Companies Mentioned
- Regeneron Pharmaceuticals Inc.
- F. Hoffmann-La Roche Ltd.
- Novartis AG
- Bayer AG
- AbbVie Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 470 |
| Published | January 2023 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 50563.47 Million |
| Forecasted Market Value ( USD | $ 112076.64 Million |
| Compound Annual Growth Rate | 8.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 5 |
